Donanemab

ATC N06DX05 · 10 markets · 11 records

Donanemab 10 markets · 11 records Forms

AU 2 records · 2 strengths

  • 17.5 mg/mLinjectionKISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 350 mg/20 mLinjectionKisunla 350mg/20ml concentrate for solution for infusion vials also in SG·CN·TW

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 350 mg/20 mLinjectionLormalzi Concentrate for Solution for Infusion 350mg/20mL also in GB·CN·TW

CN 1 records · 1 strengths

MX 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

    TW 1 records · 1 strengths

    • 350 mg/20 mLinjectionKisunla欣智樂注射劑 350毫克/20毫升 also in GB·SG·CN

    HK 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML ×1

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.